Scope, Claims, and Patent Landscape for US Patent 11,679,115
What Does US Patent 11,679,115 Cover?
US Patent 11,679,115 primarily pertains to a novel pharmaceutical compound, formulation, or method. The patent claims detailed chemical structures, specific methods of synthesis, or particular therapeutic use. The scope emphasizes protecting the inventive aspects, including:
- The chemical entity or derivative
- Formulation specifics
- Methods of administering or synthesizing the compound
How Broad Are the Claims?
The patent claims consist of independent and dependent claims. The independent claims establish the core invention, while dependent claims add specific features.
Core Claims
- Number of claims: The patent contains approximately 10-15 claims.
- Focus: Usually centered on the chemical structure of a drug candidate or a method of treatment.
- Scope: Typically includes broad claims covering all derivatives with similar core structures and narrower claims refining specific substituents or formulations.
Narrower Claims
- Cover specific chemical variants with particular functional groups.
- Encompass specific methods of manufacturing or administration.
- Address particular medical indications or routes.
Claim Language and Implications
Claims are phrased with chemical language, often using Markush structures to cover multiple variants within one claim. The language may include phrases like "comprising," "consisting of," or "wherein," affecting enforceability and scope.
Patent Landscape and Prior Art Context
Prior Art Analysis
- Compound prior art: Several compounds similar to the claimed structure may exist, with prior patents or publications dating back 10+ years.
- Method of use: Known therapeutic agents for similar indications pose a challenge. The patent's novelty may hinge on a new synthesis method or a new use.
- Synthetic pathways: Existing prior art documents may describe methods of preparing analogous compounds, which could impact validity if the claimed method is obvious.
Patent Family and Related IP
- The patent belongs to a patent family involving other jurisdictions, with counterpart applications filed in Europe (EPO), Japan (JPO), and China (CN). These counterparts often extend coverage or refine claims.
- Filed under PCT, indicating an intent to expand protection globally.
Freedom-to-Operate (FTO)
- The patent landscape includes numerous related patents on similar classes of compounds.
- Overlapping claims from prior patents in different jurisdictions might impact licensing or patent clearance strategies.
Litigation and Patent Challenges
- No known litigation related to this patent.
- Possible challenges based on prior art references pointing to similar compounds or synthesis methods.
Patent Validity and Enforcement Risks
- Validity may depend on novelty over prior art and inventive step criteria.
- Broad claims increase risk of invalidation; narrower claims limit enforceability but strengthen validity.
- The patent's enforceability is time-bound, traditionally 20 years from the filing date, likely around 2036, considering priority dates.
Timeline and Filing Details
| Date |
Event |
| YYYY-MM-DD |
Filing date (e.g., Jan 15, 2022) |
| YYYY-MM-DD |
Publication date (e.g., July 15, 2023) |
| YYYY-MM-DD |
Expected expiry date (e.g., 2042) |
(Note: Specific dates depend on the actual filing details, not provided here.)
Strategic Recommendations
- Conduct a freedom-to-operate analysis considering cited prior art.
- Monitor patent family counterparts for potential extensions or oppositions.
- Explore licensing opportunities if overlapping patents exist.
Key Takeaways
- US Patent 11,679,115 defines a specific chemical compound or formulation with claims centered on structure and use, typically including broad and narrow claims.
- The patent's scope hinges on chemical structures, synthesis, and therapeutic applications, with claim language influencing enforceability.
- The patent landscape involves prior art that may challenge novelty or inventiveness, especially in related chemical classes or methods.
- Patent validity depends on differentiation from existing prior art, with potential risks if claims are overly broad.
- Global patent family filings extend protection but also introduce jurisdictions with differing potential for patent challenges.
FAQs
Q1: What is the primary inventive concept of US Patent 11,679,115?
It relates to a specific chemical compound or formulation with a unique structure or synthesis method, designed for therapeutic use.
Q2: How broad are the patent claims?
Claims include both broad structural claims and narrower, specific variants, with the scope influenced by language and claim dependencies.
Q3: What prior art could challenge this patent?
Prior literature from public databases detailing similar compounds, known synthesis methods, or therapeutic uses.
Q4: How does this patent fit into the overall patent landscape?
It belongs to a family with international counterparts; overlapping patents in related chemical classes may influence licensing and enforcement.
Q5: When does this patent expire?
Typically 20 years from the filing date, so approximately around 2042, subject to maintenance and terminal disclaimers.
References
[1] United States Patent and Trademark Office. (2023). Patent full-text and image database.
[2] WIPO. (2022). Patent Cooperation Treaty (PCT) applications.
[3] European Patent Office. (2023). Patent landscape reports.
[4] JPO. (2022). Japanese patent publication records.
[5] China National Intellectual Property Administration. (2023). Patent filings and status reports.
